Last edition
News about
Lupin Launches Diabetes Drug Combination in the US
Lupin launches dapagliflozin and metformin extended-release tablets in the US, offering a bioequivalent and cost-effective alternative for type 2 diabetes management.
Merck Launches Bio-Based Solvents for Sustainable HPLC Applications
Merck introduces bio-based HPLC solvents made from renewable feedstocks, offering lower carbon emissions while maintaining performance for advanced laboratory and analytical applications.
Roche Secures FDA Review for Lupus Drug Gazyva
Roche’s Gazyva moves closer to approval for systemic lupus erythematosus after FDA accepts application backed by Phase III trial results showing improved disease control and remission rates.
Raay Neo Pharma Launches Operations with Focus on Expanding Access to Medicines
Raay Neo Pharma plans to introduce 90 plus formulations across acute and specialty therapies along with its entry in the India’s Pharmaceutical sector, aiming to strengthen healthcare access across multiple Indian states through a scalable and patient-centric model.<br />
Integrated DNA Technologies Expands Manufacturing Capacity to Boost Cancer Research Solutions
Integrated DNA Technologies expands its Coralville facility, tripling production capacity to support faster, scalable solutions for cancer research and next-generation sequencing applications.
SynSmart and Amporin Partner to Develop Small Molecule Therapies for Degenerative Diseases
SynSmart and Amporin collaborate to develop breakthrough small molecule therapeutics for degenerative diseases, with SynSmart creating a library of novel membrane-protecting molecules at its Mumbai research facility.
Indian Institute of Technology Kanpur appoints Prof. Anil K. Lalwani as Inaugural Dean of Gangwal School of Medical Sciences & Technology, strengthening innovation in digital health, medical robotics, and affordable healthcare solutions.
A research team from Nagaland University has developed an eco-friendly method to convert the invasive plant Mikania micrantha into silver nanoparticles, boosting drug production, antibacterial activity, and promising cancer research without toxic chemicals.
AskBio's Viralgen to Supply Commercial Drug for Parkinson's Phase 2 Trial
AskBio’s Viralgen will supply commercial-scale drug product for the REGENERATE-PD Phase II trial of ametefgene parvec (AB-1005), leveraging next-generation manufacturing to deliver high-purity gene therapy for Parkinson’s disease.
Syntegon Posts Record Year in 2025 and Aims for Further Growth
Syntegon reports a record 2025 with revenue up 10 percent to €1.75 billion and pharma sales surging 22 percent, alongside strong EBITDA and cash flow growth, reinforcing its position as a key lifecycle partner for pharma, biotech and food industries.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy